ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,242,797 | +51.4% | 193,176 | +71.5% | 0.03% | +52.4% |
| Q2 2023 | $3,462,492 | +187.4% | 112,638 | +236.9% | 0.02% | +200.0% |
| Q1 2023 | $1,204,735 | -22.0% | 33,437 | -14.5% | 0.01% | -12.5% |
| Q4 2022 | $1,544,955 | -37.8% | 39,093 | -36.8% | 0.01% | -38.5% |
| Q3 2022 | $2,485,000 | +1014.3% | 61,852 | +1065.0% | 0.01% | +1200.0% |
| Q2 2022 | $223,000 | -85.9% | 5,309 | -86.9% | 0.00% | -83.3% |
| Q1 2022 | $1,577,000 | +588.6% | 40,487 | +604.4% | 0.01% | +500.0% |
| Q4 2021 | $229,000 | -69.5% | 5,748 | -68.7% | 0.00% | -80.0% |
| Q2 2021 | $752,000 | +11.1% | 18,347 | +35.6% | 0.01% | -16.7% |
| Q4 2020 | $677,000 | – | 13,535 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $122,204,897 | 47.65% |
| Vantage Consulting Group Inc | 1,022,194 | $36,829,650 | 20.91% |
| Indie Asset Partners, LLC | 433,000 | $15,600,990 | 18.22% |
| Overbrook Management Corp | 578,783 | $20,853,551 | 5.46% |
| Silicon Valley Community Foundation | 1,032,320 | $37,194,490 | 5.36% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,047,049 | $109,785,175 | 4.64% |
| Geo Capital Gestora de Recursos Ltd | 142,748 | $5,143 | 3.81% |
| Renaissance Capital LLC | 123,913 | $4,464,585 | 3.31% |
| Rokos Capital Management LLP | 1,106,813 | $40,077,698 | 2.96% |
| Lagoda Investment Management, L.P. | 101,500 | $3,657,045 | 2.60% |